Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.402
Delayed Data
As of Jun 26
 -0.0136 / -3.27%
Today’s Change
0.31
Today|||52-Week Range
1.10
-25.56%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close0.42
Today’s open0.45
Day’s range0.40 - 0.45
Volume22,905
Average volume (3 months)46,507
Market cap$20.5M
Dividend yield--
Data as of 06/26/2017

Growth & Valuation

Earnings growth (last year)+40.69%
Earnings growth (this year)-21.05%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book6.81

Competitors

 Today’s
change
Today’s
% change
PRANPrana Biotechnology ...-0.01-0.62%
XBIOXenetic Biosciences ...+0.24+9.88%
ONTXOnconova Therapeutic...-0.01-0.48%
HTBXHeat Biologics Inc-0.00-0.03%
Data as of 06/26/2017

Financials

Next reporting dateAugust 11, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alan F. Joslyn
Chief Financial Officer, Secretary &
Treasurer
Michael O'Keefe Sullivan
Corporate headquarters
Tampa, Florida

Forecasts